Morpholino

MO1-csrnp1b

ID

ZDB-MRPHLNO-090828-6

Name

MO1-csrnp1b

Previous Names

Target

Sequence

5' - TTGAGAACCCCGCTCATGGCGCAAG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-csrnp1b

Expressed Gene	Anatomy	Figures
egr2b	presumptive rhombomere 3 presumptive rhombomere 5 rhombomere 3 rhombomere 5	Fig. 3 , Fig. 4 from Feijoo et al., 2009
emx1	forebrain forebrain neural plate	Fig. 3 , Fig. 4 from Feijoo et al., 2009
isl1a	trigeminal ganglion	Fig. 3 from Feijoo et al., 2009
pax2a	midbrain hindbrain boundary midbrain hindbrain boundary neural plate	Fig. 3 , Fig. 4 from Feijoo et al., 2009
six3a	(not) forebrain (not) midbrain hindbrain boundary	Fig. 6 from Feijoo et al., 2009
sox2	anterior neural plate presumptive rhombomere 3	Fig. 4 from Feijoo et al., 2009

Phenotype

Phenotype resulting from MO1-csrnp1b

Phenotype	Fish	Figures
cell proliferation in midbrain decreased rate, abnormal	WT + MO1-csrnp1b	Fig. 4 , Fig. 6 from Feijoo et al., 2009
eye decreased size, abnormal	WT + MO1-csrnp1b	Fig. 3 from Feijoo et al., 2009
forebrain physical object quality, abnormal	WT + MO1-csrnp1b	Fig. 6 from Feijoo et al., 2009
head decreased size, abnormal	WT + MO1-csrnp1b	Fig. 3 from Feijoo et al., 2009
midbrain hindbrain boundary malformed, abnormal	WT + MO1-csrnp1b	Fig. 3 from Feijoo et al., 2009
midbrain hindbrain boundary physical object quality, abnormal	WT + MO1-csrnp1b	Fig. 6 from Feijoo et al., 2009
neuron apoptotic process increased rate, abnormal	WT + MO1-csrnp1b	Fig. 4 , Fig. 6 from Feijoo et al., 2009
nucleate erythrocyte decreased amount, abnormal	AB/TU + MO1-csrnp1b	Fig. 3 from Espina et al., 2013
otic vesicle decreased size, abnormal	WT + MO1-csrnp1b	Fig. 3 from Feijoo et al., 2009

Phenotype of all Fish created by or utilizing MO1-csrnp1b

Phenotype	Fish	Conditions	Figures
nucleate erythrocyte decreased amount, abnormal	AB/TU + MO1-csrnp1b	standard conditions	Fig. 3 from Espina et al., 2013
cell proliferation in midbrain decreased rate, abnormal	WT + MO1-csrnp1b	standard conditions	Fig. 4 , Fig. 6 from Feijoo et al., 2009
otic vesicle decreased size, abnormal	WT + MO1-csrnp1b	standard conditions	Fig. 3 from Feijoo et al., 2009
neuron apoptotic process increased rate, abnormal	WT + MO1-csrnp1b	standard conditions	Fig. 4 , Fig. 6 from Feijoo et al., 2009
midbrain hindbrain boundary physical object quality, abnormal	WT + MO1-csrnp1b	standard conditions	Fig. 6 from Feijoo et al., 2009
eye decreased size, abnormal	WT + MO1-csrnp1b	standard conditions	Fig. 3 from Feijoo et al., 2009
forebrain physical object quality, abnormal	WT + MO1-csrnp1b	standard conditions	Fig. 6 from Feijoo et al., 2009
head decreased size, abnormal	WT + MO1-csrnp1b	standard conditions	Fig. 3 from Feijoo et al., 2009
midbrain hindbrain boundary malformed, abnormal	WT + MO1-csrnp1b	standard conditions	Fig. 3 from Feijoo et al., 2009
nucleate erythrocyte decreased amount, abnormal	AB/TU + MO1-csrnp1b + MO2-csrnp1a	standard conditions	Fig. 3 from Espina et al., 2013

Citations